OSMOTICA PHARMACEUTICALS PLC (OSMT) Stock Income Statement
NASDAQ:OSMT - Nasdaq - Common Stock
| TTM (2021-9-30) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 73.05M | 177.90M | 240.00M | 263.70M | 245.70M | |||
| Cost Of Goods | 33.20M | 74.50M | 111.60M | 140.10M | 125.20M | |||
| Gross Profit | 39.85M | 103.40M | 128.40M | 123.60M | 120.60M | |||
| Operating Expenses | 116.99M | 101.60M | 125.40M | 117.90M | 99.60M | |||
| Research and Development | 13.61M | 19.70M | 32.30M | 43.70M | 42.70M | |||
| Selling, General, and Administrative Expenses | 103.38M | 82.00M | 93.00M | 74.20M | 57.00M | |||
| Operating Income | -77.14M | 1.80M | 3.00M | 5.70M | 21.00M | |||
| Interest Income/Expense | -7.74M | -14.40M | -18.20M | -20.80M | -29.10M | |||
| Other Income/Expense | -912.00K | 500.00K | 900.00K | 700.00K | 500.00K | |||
| Non Recurring Items | -45.63M | -72.20M | -283.70M | -104.20M | -78.00M | |||
| Income Before Taxes | -131.43M | -84.30M | -298.00M | -118.70M | -85.60M | |||
| Income Tax | -3.77M | -4.70M | -27.10M | -9.00M | -44.50M | |||
| Net Income | -109.68M | -79.60M | -270.90M | -109.70M | -41.10M | |||
| EBITDA | -64.63M | 22.83M | 60.02M | 87.27M | 67.45M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.75 | -1.31 | -5.17 | -2.42 | -0.96 | |||
| Non GAAP EPS | -1.59 | -1.29 | -2.73 | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 54.55% | 58.12% | 53.50% | 46.87% | 49.08% | |||
| Profit Margin | -150.14% | -44.74% | -112.87% | -41.60% | -16.73% | |||
| Operating Profit Margin | -105.60% | 1.01% | 1.25% | 2.16% | 8.55% | |||
All data in USD